glp-1 weight loss oral US FDA accepts Novo Nordisk's application for Wegovy for Best GLP-1 for Weight Loss:

While effective for weight loss and diabetes control, these effects can pose risks during pregnancy: Possible birth defects Animal studies indicate potential risks to fetal development

What the evidence says Early research is encouraging but still limited

Patients often find they: Naturally choose smaller portions Stop eating when satisfied rather than overly full Snack less between meals Feel more in control around food This makes lifestyle changes easier to maintain over time, rather than feeling like a temporary diet

When considering the timeline of GLP-1 medication, its helpful to remember that progress is gradual

Tirzepatide on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial